Dudediligence.

Allarity Therapeutics, Inc

ALLRNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

15.9M

on 2026-06-30, from 1.17M on 2024-06-30 10-Q ↗

Earlier counts are adjusted for the 1-for-30 reverse split; each bar's tip shows the count as filed.

Counts before 2024-06-30 are left out: the count went from 11K on 2024-03-31 to 1.17M on 2024-06-30, a change no split on file explains.

a raise that quarter, at its price

Newest

$50.0M

S-3 of 2025-12-03. 1 prospectus supplement filed under it since. S-3 ↗

17 of its filings are not read yet.

Warrants

28K

Warrants of every class as tagged in the XBRL facts on 2024-03-14. Adjusted for the 1-for-30 reverse split. 10-Q ↗

Cash

5 quarters

$17.0M on 2026-06-30 ÷ $3.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-01-28Public offeringnot readnot readnot read424B5 ↗
2025-12-23Private placement255,103not read$250K8-K ↗
2025-09-22Private placement1,562,500not read$2.5M8-K ↗